Dr. Schachter specializes in ocular surface disease and serves as a Vision Source administrator for central California coast. He serves on the advisory board for Allergan, BlephEx, Sun Pharma, and ScienceBased Health, and he is a speaker for Allergan, Bau
Scott Schachter, OD, explains why competition in the optometric marketplace drives innovation, lowers prices, gives more offerings, and provides better ways for ODs to treat patients.
The views expressed here belong to the author. They do not necessarily represent the views of Optometry Times or MultiMedia Healthcare LLC.
